Immunotherapy in head and neck squamous cell carcinoma: oncologic and functional outcomes.
PURPOSE OF REVIEW This review summarizes the evidence supporting the use of immunotherapy across the full disease spectrum of head and neck squamous cell carcinoma (HNSCC) from early-stage, curative-intent settings to recurrent/metastatic disease. It also examines emerging data on swallowing outcomes and outlines the i...